(22 days)
Not Found
No
The summary explicitly states that the only modifications were related to the power supply (changing from AC to battery) and accompanying labeling changes. There is no mention of any software or algorithmic changes, particularly those related to AI or ML. The "Mentions AI, DNN, or ML" section is also marked as "Not Found".
No
The device is described as an ultrasonic imaging instrument intended for diagnostic purposes, not for therapeutic intervention.
Yes
The "Intended Use / Indications for Use" section states the device is an "ultrasonic imaging instrument intended for use by a qualified physician for evaluation of Abdomen, Cardiac, Small Organ... etc.", and the "Device Description" explicitly mentions it is "intended for clinical diagnostic imaging applications." Furthermore, the predicate device it is compared to is named the "SonoScape S8 Diagnostic Ultrasound System".
No
The device description explicitly states it is an "integrated preprogrammed color ultrasound imaging system" and details a change in its power supply from AC to battery, indicating it is a hardware device with integrated software, not a software-only device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states that the device is a "general-purpose ultrasonic imaging instrument intended for use by a qualified physician for evaluation of Abdomen, Cardiac, Small Organ...". This describes a device used for imaging the body directly, not for testing samples (like blood, urine, or tissue) outside of the body.
- Device Description: The description focuses on the ultrasound imaging capabilities and the power source change. It does not mention any components or functions related to analyzing biological samples.
- Input Imaging Modality: The input modality is "Diagnostic Ultrasound," which is an imaging technique applied to the patient's body.
- Anatomical Site: The listed anatomical sites are all parts of the human body.
IVD devices are specifically designed to examine specimens derived from the human body to provide information for diagnosis, monitoring, or screening. This device is used for direct imaging of the body, which falls under the category of medical imaging devices, not IVDs.
N/A
Intended Use / Indications for Use
The SonoScape S8 device is a general-purpose ultrasonic imaging instrument intended for use by a qualified physician for evaluation of Abdomen, Cardiac, Small Organ (breast, testes, thyroid), Peripheral Vascular, Musculo-skeletal (Conventional and Superficial), Pediatric, Fetal, Cephalic, OB/Gyn and Urology. This is the same intended use as previously cleared for the SonoScape S8 Diagnostic Ultrasound System, K092922.
Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
- Fetal Imaging & Other: Fetal, Abdominal, Pediatric, Small Organ (breast, thyroid, testes), Neonatal Cephalic, Adult Cephalic, Trans-rectal, Trans-vaginal, Musculo-skeletal (Conventional), Musculo-skeletal (Superficial), Ob/GYN
- Cardiac: Cardiac Adult, Cardiac Pediatric
- Peripheral Vessel: Peripheral vessel
Product codes (comma separated list FDA assigned to the subject device)
1YN, 1YO, ITX
Device Description
The SonoScape S8 Ultrasound System, previously cleared under K092922, is an integrated preprogrammed color ultrasound imaging system, capable of producing high detail resolution intended for clinical diagnostic imaging applications.
The only modifications that were made are: The original S8 Diagnostic Ultrasound System, was previously cleared in K092922 dated March 12, 2009, uses an internal SMPS as its power supply system. And the proposed device was redesigned, changing from AC to battery power, i.e. the internal Li-ion Battery Pack (with an external AC adapter). Such a change is accompanied by labeling changes, but not including new indication for use (See Tab 3).
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Ultrasound
Anatomical Site
Abdomen, Cardiac, Small Organ (breast, testes, thyroid), Peripheral Vascular, Musculo-skeletal (Conventional and Superficial), Pediatric, Fetal, Cephalic, OB/Gyn, Urology, Intra-operative Neuro, Laparoscopic, Trans-rectal, Trans-vaginal, Trans-urethral, Trans-esoph. (non-Card), Intravascular, Intra-cardiac
Indicated Patient Age Range
Pediatric, Neonatal, Adult, Fetal
Intended User / Care Setting
Qualified physician
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Laboratory testing was conducted to verify that the S8 Diagnostic Ultrasound System met all design specification and was substantially equivalent to the currently marketed Predicate Device as above. The device has been found to conform to applicable medical device safety standards in regards to thermal, mechanical and electrical safety as well as biocompatibility. Acoustic output is measured and calculated according to "Acoustic Output Measuring Standard for Diagnostic Ultrasound Equipment".
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.1550 Ultrasonic pulsed doppler imaging system.
(a)
Identification. An ultrasonic pulsed doppler imaging system is a device that combines the features of continuous wave doppler-effect technology with pulsed-echo effect technology and is intended to determine stationary body tissue characteristics, such as depth or location of tissue interfaces or dynamic tissue characteristics such as velocity of blood or tissue motion. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II.
0
S8 Diagnostic Ultrasound System
Tab 19 PREMARKET NOTIFICATION 510(K) SUMMARY
This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR §807.92.
The assigned 510(k) number is:
Manufacturer:
SonoScape Company Limited
Address: 4/F., Yizhe Building, Yuquan Road,Nanshan, Shenzhen 518051,
P.R.China
Tel: (86) 755-26722890
Fax: (86) 755-26722850
Contact Person: Chen Zhiqiang
Date Prepared: July 12, 2011
Name of the device:
-
- Trade/Proprietary Name:
- S8 Diagnostic Ultrasound System
-
- Common Name: Diagnostic Ultrasound System and Transducers
-
- Classification:
Regulatory Class: II
Review Category: Tier II
- 21 CFR 892.1550 Ultrasonic Pulsed Doppler Imaging System (90-IYN)
- 21 CFR 892.1560 Ultrasonic Pulsed Echo Imaging System (90-IYO)
- 21 CFR 892.1570 Diagnostic Ultrasound Transducer (90-ITX)
Legally Marketed Predicate Device:
K092922, SonoScape S8 Diagnostic Ultrasound System
Premarket Notification 510(k) Summary
1
Device Description:
The SonoScape S8 Ultrasound System, previously cleared under K092922, is an integrated preprogrammed color ultrasound imaging system, capable of producing high detail resolution intended for clinical diagnostic imaging applications.
The only modifications that were made are:
The original S8 Diagnostic Ultrasound System, was previously cleared in K092922 dated March 12, 2009, uses an internal SMPS as its power supply system. And the proposed device was redesigned, changing from AC to battery power, i.e. the internal Li-ion Battery Pack (with an external AC adapter). Such a change is accompanied by labeling changes, but not including new indication for use (See Tab 3).
Table 21.1 lists the differences between the two power supply systems.
| Model
Item | S8
K092922
(with SMPS) | S8
TBD
(with Battery Pack and AC Adapter) |
|------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Power
supply | No battery pack is provided;
The SMPS forms the power
supply system. | An internal battery pack is provided;
The power supply system consists of
the AC adapter and DC converter
and a Li-ion Battery Pack. |
| Working
Principle of
the Power
Supply | The SMPS converts the 220V
or 110V mains voltage to the
DC voltages (+12V, -12V, +5V,
+3.3V, +5VSB) required by all
the electronic parts in the S8
Series System. | The AC adapter converts the mains
voltage (100-240V AC) to a DC
voltage of approximately +17.5V.
Supplied with this DC voltage, the
DC converter charges the battery
and also converts the DC voltage to
the lower voltages (+12V, -12V, +5V,
+3.3V, +5VSB) required by all the
electronic parts in the S8 system,
and at the same time controls the
LED indicators on the control
panel/keyboard. |
Table 21.1 Comparison of the Switching Mode Power Supply (SMPS) System and the Battery Pack Power Supply System
2
SonoScape Company LTD | S8 Diagnostic Ultrasound System | |
---|---|---|
Model | ||
Item | S8 | |
K092922 | ||
(with SMPS) | S8 | |
TBD | ||
(with Battery Pack and AC Adapter) | ||
Control | ||
Panel/ | ||
Keyboard | / | Compared to control panel of the |
original certified product, three LEDs | ||
have been added at the bottom right | ||
corner of the control panel. | ||
Remarks | 1)Since the original S8 System does not have internal battery, it | |
requires the mains supply to operate. When no mains supply is | ||
provided, the system can not be turned on. | ||
2)With the Li-ion Battery Pack, the S8 System can operate even | ||
when no mains supply is available. |
Intended Use:
The SonoScape S8 device is a general-purpose ultrasonic imaging instrument intended for use by a qualified physician for evaluation of Abdomen, Cardiac, Small Organ (breast, testes, thyroid), Peripheral Vascular, Musculo-skeletal (Conventional and Superficial), Pediatric, Fetal, Cephalic, OB/Gyn and Urology. This is the same intended use as previously cleared for the SonoScape S8 Diagnostic Ultrasound System, K092922.
Probe Information:
No. | Probe | Type | Frequency Range | Intended Use |
---|---|---|---|---|
1 | 2P1 | Phased Array | 2.0-4.0 MHz | Abdominal |
Neonatal Cephalic | ||||
Adult Cephalic | ||||
Cardiac Adult | ||||
Cardiac Pediatric | ||||
2 | 5P1 | Phased Array | 3.0-7.0 MHz | Pediatric |
Neonatal Cephalic | ||||
Cardiac Pediatric | ||||
3 | 6V1 | Micro-curved | ||
Array | 4.0-8.0 MHz | Trans-rectal | ||
Trans-vaginal | ||||
4 | 6V3 | Micro-curved | ||
Array | 5.0-9.0 MHz | Trans-rectal | ||
Trans-vaginal | ||||
5 | EC9-5 | Micro-curved | ||
Array | 5.0-9.0 MHz | Trans-rectal | ||
Trans-vaginal | ||||
6 | C611 | Micro-curved | ||
Array | 4.0-8.0 MHz | Abdominal | ||
Pediatric | ||||
Neonatal Cephalic | ||||
Cardiac Pediatric |
Tab 21.2 Probe information
Premarket Notification 510(k) Summary
3
SonoScape Company LTD
S8 Diagnostic Ultrasound System
No. | Probe | Type | Frequency Range | Intended Use |
---|---|---|---|---|
7 | C344 | Curved Array | 2.0-5.0 MHz | Fetal / Abdominal/ Ob/GYN |
8 | C362 | Curved Array | 2.0-6.0 MHz | Fetal / Abdominal/ Ob/GYN |
9 | VC6-2 | Curved Array | 2.0-6.0 MHz | Fetal / Abdominal/ Ob/GYN |
10 | L741 | Linear Array | 5.0-10.0 MHz | Small Organ (breast, thyroid, testes) |
Musculo-skeletal (Conventional) | ||||
Peripheral vessel | ||||
11 | L742 | Linear Array | 5.0-12.0 MHz | Small Organ (breast, thyroid, testes) |
Musculo-skeletal (Conventional) | ||||
Musculo-skeletal (Superficial) | ||||
Peripheral vessel | ||||
12 | L743 | Linear Array | 5.0-10.0 MHz | Small Organ (breast, thyroid, testes) |
Musculo-skeletal (Conventional) | ||||
Musculo-skeletal (Superficial) | ||||
Peripheral vessel |
Safety Considerations:
The S8 Diagnostic Ultrasound System incorporates the same fundamental technology as the predicate device. The device has been tested as Track 3 Device per the FDA Guidance document "Information for Manufacturers Seeking Marketing Clearance of Diagnostic Ultrasound Systems and Transducers" issued September 9, 2008. The acoustic output is measured and calculated per NEMA UD 2: 2004 Acoustic Output Measurement Standard for Diagnostic Ultrasound Equipment and NEMA UD3: 2004 Standards for Real-time Display of Thermal and Mechanical Acoustic Output Indices on Diagnostic Ultrasound Equipment. The device conforms to applicable medical device safety standards, such as IEC 60601-1, IEC 60601-1-1, IEC 60601-1-2, IEC 60601-2-37, ISO 10993-5 and ISO 10993-10.
Testing:
Laboratory testing was conducted to verify that the S8 Diagnostic Ultrasound System met all design specification and was substantially equivalent to the currently marketed Predicate Device as above. The device has been found to
4
SonoScape Company LTD
conform to applicable medical device safety standards in regards to thermal, mechanical and electrical safety as well as biocompatibility. Acoustic output is measured and calculated according to "Acoustic Output Measuring Standard for Diagnostic Ultrasound Equipment".
Standards No. | Standards Title | Version | Date |
---|---|---|---|
IEC 60601-1 | IEC 60601-1, Medical Electrical Equipment - Part 1: | ||
General Requirements for Safety, 1988; | |||
Amendment 1, 1991-11, Amendment 2, 1995. | 1988 | 10/31/2005 | |
IEC 60601-1-2 | IEC 60601-1-2, (Second Edition, 2001), Medical | ||
Electrical Equipment - Part 1-2: General | |||
Requirements for Safety - Collateral Standard: | |||
Electromagnetic Compatibility - Requirements and | |||
Tests. | 2007 | 07/31/2008 | |
IEC | |||
60601-2-37 | IEC 60601-2-37 (2004) (2005) Amendment 2, | ||
Medical electrical equipment - Part 2-37: Particular | |||
requirements for the basic safety and essential | |||
performance of ultrasonic medical diagnostic and | |||
monitoring equipment. | 2007 | 09/08/2009 | |
NEMA UD 2 | NEMA UD 2-2004, Acoustic Output Measurement | ||
Standard for Diagnostic Ultrasound Equipment | |||
Version 3. | 2004 | 09/08/2009 | |
ISO 10993-5 | ISO 10993-5:1999, Biological evaluation of medical | ||
devices -- Part 5: Tests for In Vitro cytotoxicity. | 2009 | 09/12/2007 | |
10993-10 | ISO 10993-10:2002, Biological evaluation of | ||
medical devices - Part 10: Tests for irritation and | |||
delayed-type hypersensitivity. | 2002 | 09/12/2007 |
Tab 21.3 Applicable Safety Standards
Conclusion:
The conclusions drawn from testing of the S8 Diagnostic Ultrasound System demonstrate that the device is as safe and effective as the legally marketed predicate devices.
5
Image /page/5/Picture/1 description: The image shows a logo with a stylized bird-like symbol on the right and a circular arrangement of text on the left. The text appears to be "U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES". The bird-like symbol is composed of curved lines, giving it a sense of motion or flight.
Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993
SonoScape Company Limited % Ms. Diana Hong General Manager Mid-Link Consulting Co., Ltd P.O. Box 237-023 Shanghai, 200237 CHINA
SEP 16 2011
Re: K112451
Trade/Device Name: S8 Diagnostic Ultrasound System Regulation Number: 21 CFR 892.1550 Regulation Name: Ultrasonic pulsed doppler imaging system Regulatory Class: II Product Code: 1YN, 1YO, and ITX Dated: August 24. 2011 Received: August 25. 2011
Dear Ms. Hong:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
This determination of substantial equivalence applies to the following transducers intended for use with the S8 Diagnostic Ultrasound System, as described in your premarket notification:
Transducer Model Number
2P1 Phase Arrav 5P1 Phase Array 6V ! Micro-curved Array 6V3 Micro-curved Array EC9-5 Micro-curved Arrav C611 Micro-curved Array C362 Curved Array C344 Curved Array
VC6-2 Curved Array L743 Linear Array L741 Linear Array L742 Linear Array
6
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807): labeling (21 CFR Part 801): good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing vour device as described in your premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus permits your device to proceed to market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803). please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
If you have any questions regarding the content of this letter, please contact Shahram Vaezy, Ph.D. at (301) 796-6242.
Sincerely Yours.
Mary S Postiff
Mary S. Pastel. Sc.D. Director Division of Radiological Devices Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health
Enclosure(s)
7
Tab 3 Indications For Use
510(k) Number: Device Name: S8 Diagnostic Ultrasound System
- Indications for Use: The SonoScape S8 device is a general-purpose ultrasonic imaging instrument intended for use by a qualified physician for evaluation of Abdomen, Cardiac, Small Organ (breast, testes, thyroid), Peripheral Vascular, Musculo-skeletal (Conventional and Superficial), Pediatric, Fetal, Cephalic, OB/Gyn and Urology.
Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)
May S. Patel
(Division Sign-Off) Division of Radiological Devices Office of In Vitro Diagnostic Device Evaluation and Safety
510(k) Number K112451
8
System: Sonoscape S8 Diagnostic Ultrasound Pulsed Echo System Diagnostic Ultrasound Pulsed Doppler Imaging System
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application | Mode of Operation | ||||||||
---|---|---|---|---|---|---|---|---|---|
General | |||||||||
(TRACK 1 | |||||||||
ONLY) | Specific | ||||||||
(TRACKS 1 & 3) | B | M | PWD | CWD | Color | ||||
Doppler | Power | ||||||||
(Amplitude) | |||||||||
Doppler | Other* | ||||||||
Combined | Other* | ||||||||
Specify | |||||||||
Ophthalmic | Ophthalmic | ||||||||
Fetal | |||||||||
Imaging& | |||||||||
Other | Fetal | P | P | P | P | P | Note 1 | Notes 2,4,5 | |
Abdominal | P | P | P | P | P | Note 1 | Notes 2,4,5 | ||
Intra-operative Specify | |||||||||
Intra-operative Neuro | |||||||||
Laparoscopic | |||||||||
Pediatric | P | P | P | P | P | Note 1 | Notes 2,4 | ||
Small Organ (specify) | P | P | P | P | P | Note 1 | Notes 2,4,6 | ||
Neonatal Cephalic | P | P | P | P | P | P | Note 1 | Notes 24 | |
Adult Cephalic | P | P | P | P | P | P | Note 1 | Notes 2, 4 | |
Trans-rectal | P | P | P | P | P | Note 1 | Notes 2 | ||
Trans-vaginal | P | P | P | P | P | Note 1 | Notes 2 | ||
Trans-urethral | |||||||||
Trans-esoph.(non-Card) | |||||||||
Musculo-skeletal | |||||||||
(Conventional) | P | P | P | P | P | Note 1 | Notes 2,4 | ||
Musculo-skeletal | |||||||||
(Superficial) | P | P | P | P | P | Note 1 | Notes 2,4 | ||
Intravascular | |||||||||
Other (Ob/GYN) | P | P | P | P | P | Note 1 | Notes 2,4,5 | ||
Cardiac | Cardiac Adult | P | P | P | P | P | P | Note 1 | Notes 2,3 |
Cardiac Pediatric | P | P | P | P | P | P | Note 1 | Notes 2,3 | |
Intravascular(Cardiac) | |||||||||
Trans-esoph.(Cardiac) | |||||||||
Intra-cardiac | |||||||||
Other (specify) | |||||||||
Peripheral | |||||||||
Vessel | Peripheral vessel | P | P | P | P | P | Note 1 | Notes 2 | |
Other (specify) |
N = new indication;
Prescription Use
P = previously cleared by FDA;
E = added under this appendix
Note 1: Other Combined includes: B/M; B/PWD; B/THI; M/Color M ; B/Color Doppler; B/Color Doppler/PWD; B/Power Doppler/PWD
Note 2: Tissue Harmonic Imaging.
(Part 21 CFR 801 Subpart D)
Note 5: 4D
Note 3: TDI Note 6: Small Organ: breast, thyroid, testes
X
Note 4: 3D
AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)
510
Mary S. Patel
(Division Sign Off)
Indications For Use
Division Sign Division of Pradiological Devices Office of In Vitro Diagnostic Device Evaluation and Safety
3-2
9
Transducer: 2P1 Phase Array
Diagnostic Ultrasound Transducer
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application | Mode of Operation | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
General | |||||||||||
(TRACK 1 | |||||||||||
ONLY) | Specific | ||||||||||
(TRACKS 1 & 3) | B | M | PWD | CWD | Color | ||||||
Doppler | Power | ||||||||||
(Amplitude) | |||||||||||
Doppler | Other* | ||||||||||
Combined | Other* | ||||||||||
Specify | |||||||||||
Ophthalmic | Ophthalmic | ||||||||||
Fetal | |||||||||||
Imaging& | Fetal | ||||||||||
Other | Abdominal | P | P | P | P | P | Note 1 | Notes 2 | |||
Intra-operative Specify | |||||||||||
Intra-operative Neuro | |||||||||||
Laparoscopic | |||||||||||
Pediatric | |||||||||||
Small Organ (specify) | |||||||||||
Neonatal Cephalic | P | P | P | P | P | P | Note 1 | Notes 2 | |||
Adult Cephalic | P | P | P | P | P | P | Note 1 | Notes 2 | |||
Trans-rectal | |||||||||||
Trans-vaginal | |||||||||||
Trans-urethral | |||||||||||
Trans-esoph. (non-Card) | |||||||||||
Musculo-skeletal | |||||||||||
(Conventional) | |||||||||||
Musculo-skeletal | |||||||||||
(Superficial) | |||||||||||
Intravascular | |||||||||||
Other (Ob/GYN) | |||||||||||
Cardiac | Cardiac Adult | P | P | P | P | P | P | Note 1 | Notes 2,3 | ||
Cardiac Pediatric | P | P | P | P | P | P | Note 1 | Notes 2,3 | |||
Intravascular(Cardiac) | |||||||||||
Trans-esoph.(Cardiac) | |||||||||||
Intra-cardiac | |||||||||||
Other (specify) | |||||||||||
Peripheral | Peripheral vessel | ||||||||||
Vessel | Other (specify) |
N = new indication; P = previously cleared by FDA; E = added under this appendix Note 1: Other Combined includes: B/M: B/PWD: B/THI; M/Color M : B/Color Doppler; B/Color Doppler;PWD; B/Power Doppler/PWD
Note 2: Tissue Harmonic Imaging.
Note 3: TDI Note 4: 3D
Note 6: Small Organ: breast, thyroid, testes
Prescription Use X (Part 21 CFR 801 Subpart D)
AND/OR
Note 5: 4D
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)
Man S. Patel
sion Sio Division of Radiological D Office of In
610K K112451
3-3
Indications For Use
10
Transducer: 5P1 Phase Array Diagnostic Ultrasound Transducer
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application | Mode of Operation | ||||||||
---|---|---|---|---|---|---|---|---|---|
General | |||||||||
(TRACK 1 | |||||||||
ONLY) | Specific | ||||||||
(TRACKS 1 & 3) | B | M | PWD | CWD | Color | ||||
Doppler | Power | ||||||||
(Amplitude) | |||||||||
Doppler | Other* | ||||||||
Combined | Other* | ||||||||
Specify | |||||||||
Ophthalmic | Ophthalmic | ||||||||
Fetal | |||||||||
Imaging& | |||||||||
Other | Fetal | ||||||||
Abdominal | |||||||||
Intra-operative Specify | |||||||||
Intra-operative Neuro | |||||||||
Laparoscopic | |||||||||
Pediatric | P | P | P | P | P | Note 1 | Notes 2 | ||
Small Organ (specify) | |||||||||
Neonatal Cephalic | P | P | P | P | P | P | Note 1 | Notes 2 | |
Adult Cephalic | |||||||||
Trans-rectal | |||||||||
Trans-vaginal | |||||||||
Trans-urethral | |||||||||
Trans-esoph. (non-Card) | |||||||||
Musculo-skeletal | |||||||||
(Conventional) | |||||||||
Musculo-skeletal | |||||||||
(Superficial) | |||||||||
Intravascular | |||||||||
Other (Ob/GYN) | |||||||||
Cardiac | Cardiac Adult | ||||||||
Cardiac Pediatric | P | P | P | P | P | P | Note 1 | Notes 2,3 | |
Intravascular(Cardiac) | |||||||||
Trans-esoph. (Cardiac) | |||||||||
Intra-cardiac | |||||||||
Other (specify) | |||||||||
Peripheral | |||||||||
Vessel | Peripheral vessel | ||||||||
Other (specify) |
P = previously cleared by E
appendix
Note 1: Other Combined includes: B/M; B/PWD; B/TH; M/Color M ; B/Color Doppler; B/Color Doppler/PWD; B/Power Doppler/PWD
Note 2: Tissue Harmonic Imaging.
Note 3: TDI Note 4: 3D
Note 6: Small Organ: breast, thyroid, testes
Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR
Note 5: 4D
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)
Indications For Use
Mary S. Patel
3-4
Division of Radiological Di Office of In Vitro Diagnostic De
510K
11
Transducer: 6V1 Micro-curved Array Diagnostic Ultrasound Transducer
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application | Mode of Operation | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
General | |||||||||||
(TRACK 1 | |||||||||||
ONLY) | Specific | ||||||||||
(TRACKS 1 & 3) | B | M | PWD | CWD | Color | ||||||
Doppler | Power | ||||||||||
(Amplitude) | |||||||||||
Doppler | Other* | ||||||||||
Combined | Other* | ||||||||||
Specify | |||||||||||
Ophthalmic | Ophthalmic | ||||||||||
Fetal | Fetal | ||||||||||
Imaging& | |||||||||||
Other | Abdominal | ||||||||||
Intra-operative Specify | |||||||||||
Intra-operative Neuro | |||||||||||
Laparoscopic | |||||||||||
Pediatric | |||||||||||
Small Organ (specify) | |||||||||||
Neonatal Cephalic | |||||||||||
Adult Cephalic | |||||||||||
Trans-rectal | P | P | P | P | P | Note 1 | Notes 2 | ||||
Trans-vaginal | P | P | P | P | P | Note 1 | Notes 2 | ||||
Trans-urethral | |||||||||||
Trans-esoph. (non-Card) | |||||||||||
Musculo-skeletal | |||||||||||
(Conventional) | |||||||||||
Musculo-skeletal | |||||||||||
(Superficial) | |||||||||||
Intravascular | |||||||||||
Other (Ob/GYN) | |||||||||||
Cardiac | Cardiac Adult | ||||||||||
Cardiac Pediatric | |||||||||||
Intravascular(Cardiac) | |||||||||||
Trans-esoph. (Cardiac) | |||||||||||
Intra-cardiac | |||||||||||
Other (specify) | |||||||||||
Peripheral | |||||||||||
Vessel | Peripheral vessel | ||||||||||
Other (specify) | |||||||||||
N = new indication; | Note 1: Other Combined includes: B/M; B/PWD; B/THI; M/Color M; B/Color Doppler; B/Color Doppler/PWD; B/Power | ||||||||||
Doppler/PWD | P = previously cleared by FDA; | E = added under this appendix | |||||||||
Note 2: Tissue Harmonic Imaging. | |||||||||||
Note 3: TDI | Note 4: 3D | Note 5: 4D | |||||||||
Note 6: Small Organ: breast, thyroid, testes | |||||||||||
Prescription Use | X | AND/OR | Over The Counter Use |
(Part 21 CFR 801 Subpart D)
(21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)
Indications For Use
Maus. Potel 3-5
(Division Sign-Off)
Division of Radiologica Office of In and Sefety
510K K1124/S1
12
Transducer: 6V3 Micro-curved Array Diagnostic Ultrasound Transducer
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application | Mode of Operation | Other* | |||||||
---|---|---|---|---|---|---|---|---|---|
General | |||||||||
(TRACK 1 | |||||||||
ONLY) | Specific | ||||||||
(TRACKS 1 & 3) | B | M | PWD | CWD | Color | ||||
Doppler | Power | ||||||||
(Amplitude) | |||||||||
Doppler | Combined | Specify | |||||||
Ophthalmic | Ophthalmic | ||||||||
Fetal | |||||||||
Imaging& | |||||||||
Other | Fetal | ||||||||
Abdominal | |||||||||
Intra-operative Specify | |||||||||
Intra-operative Neuro | |||||||||
Laparoscopic | |||||||||
Pediatric | |||||||||
Small Organ (specify) | |||||||||
Neonatal Cephalic | |||||||||
Adult Cephalic | |||||||||
Trans-rectal | P | P | P | P | P | Note 1 | Notes 2 | ||
Trans-vaginal | P | P | P | P | P | Note 1 | Notes 2 | ||
Trans-urethral | |||||||||
Trans-esoph.(non-Card) | |||||||||
Musculo-skeletal | |||||||||
(Conventional) | |||||||||
Musculo-skeletal | |||||||||
(Superficial) | |||||||||
Intravascular | |||||||||
Other (Ob/GYN) | |||||||||
Cardiac | Cardiac Adult | ||||||||
Cardiac Pediatric | |||||||||
Intravascular(Cardiac) | |||||||||
Trans-esoph.(Cardiac) | |||||||||
Intra-cardiac | |||||||||
Other (specify) | |||||||||
Peripheral | |||||||||
Vessel | Peripheral vessel | ||||||||
Other (specify) | |||||||||
N = new indication; | |||||||||
P = previously cleared by FDA; | |||||||||
E = added under this appendix |
P = previously cleared by FDA;
E = added under this appendix
Note 1: Other Combined includes: B/M; B/PWD; B/THI; M/Color M ; B/Color Doppler; B/Color Doppler/PWD; B/Power Doppler/PWD
Note 2: Tissue Harmonic Imaging.
Note 3: TDI Note 4: 3D
Note 6: Small Organ: breast, thyroid, testes
Prescription Use X (Part 21 CFR 801 Subpart D)
AND/OR
Note 5: 4D
Over-The-Counter Use _ . (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)
Indications For Use
Mays Patel
(Division Sign-Off)
Division of Radiological Devices Division of Radiological Devices
Office of In Vitro Diagnostic Device Evaluation and Safety
I
510K K12451
3-6
13
Transducer: EC9-5 Micro-curved Array Diagnostic Ultrasound Transducer
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application | Mode of Operation | Other* | |||||||
---|---|---|---|---|---|---|---|---|---|
General | |||||||||
(TRACK 1 | |||||||||
ONLY) | Specific | ||||||||
(TRACKS 1 & 3) | B | M | PWD | CWD | Color | ||||
Doppler | Power | ||||||||
(Amplitude) | |||||||||
Doppler | Other* | ||||||||
Combined | Other* | ||||||||
Specify | |||||||||
Ophthalmic | Ophthalmic | ||||||||
Fetal | |||||||||
Imaging& | |||||||||
Other | Fetal | ||||||||
Abdominal | |||||||||
Intra-operative Specify | |||||||||
Intra-operative Neuro | |||||||||
Laparoscopic | |||||||||
Pediatric | |||||||||
Small Organ (specify) | |||||||||
Neonatal Cephalic | |||||||||
Adult Cephalic | |||||||||
Trans-rectal | P | P | P | P | P | Note 1 | Notes 2 | ||
Trans-vaginal | P | P | P | P | P | Note 1 | Notes 2 | ||
Trans-urethral | |||||||||
Trans-esoph.(non-Card) | |||||||||
Musculo-skeletal | |||||||||
(Conventional) | |||||||||
Musculo-skeletal | |||||||||
(Superficial) | |||||||||
Intravascular | |||||||||
Other (Ob/GYN) | |||||||||
Cardiac | Cardiac Adult | ||||||||
Cardiac Pediatric | |||||||||
Intravascular(Cardiac) | |||||||||
Trans-esoph. (Cardiac) | |||||||||
Intra-cardiac | |||||||||
Other (specify) | |||||||||
Peripheral | |||||||||
Vessel | Peripheral vessel | ||||||||
Other (specify) | |||||||||
P = previously cleared by FDA; | |||||||||
E = added under this appendix | |||||||||
N = new indication; |
P = previously cleared by FDA;
E = added under this appendix
Note 1: Other Combined includes: B/M; B/PWD; B/TH; M/Color Doppler; B/Color Doppler/PWD; B/Power Doppler/PWD
Note 5: 4D
Note 2: Tissue Harmonic Imaging.
Note 3: TDI Note 4: 3D
Note 6: Small Organ: breast, thyroid, testes
Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)
・
Indications For Use
Mary S Patel 3-7
(Division Sign-Off)
Office of In and Safety
510K
14
Transducer: C611 Micro-curved Array Diagnostic Ultrasound Transducer
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application | Mode of Operation | Other* | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
General | ||||||||||
(TRACK 1 | ||||||||||
ONLY) | Specific | |||||||||
(TRACKS 1 & 3) | B | M | PWD | CWD | Color | |||||
Doppler | Power | |||||||||
(Amplitude) | ||||||||||
Doppler | Combined | Specify | ||||||||
Ophthalmic | Ophthalmic | |||||||||
Fetal | ||||||||||
Imaging& | ||||||||||
Other | Fetal | |||||||||
Abdominal | P | P | P | P | P | Note 1 | Notes 2 | |||
Intra-operative Specify | ||||||||||
Intra-operative Neuro | ||||||||||
Laparoscopic | ||||||||||
Pediatric | P | P | P | P | P | Note 1 | Notes 2 | |||
Small Organ (specify) | ||||||||||
Neonatal Cephalic | P | P | P | P | P | P | Note 1 | Notes 2 | ||
Adult Cephalic | ||||||||||
Trans-rectal | ||||||||||
Trans-vaginal | ||||||||||
Trans-urethral | ||||||||||
Trans-esoph.(non-Card) | ||||||||||
Musculo-skeletal | ||||||||||
(Conventional) | ||||||||||
Musculo-skeletal | ||||||||||
(Superficial) | ||||||||||
Intravascular | ||||||||||
Other (Ob/GYN) | ||||||||||
Cardiac | Cardiac Adult | |||||||||
Cardiac Pediatric | P | P | P | P | P | P | Note 1 | Notes 2,3 | ||
Intravascular(Cardiac) | ||||||||||
Trans-esoph.(Cardiac) | ||||||||||
Intra-cardiac | ||||||||||
Other (specify) | ||||||||||
Peripheral | ||||||||||
Vessel | Peripheral vessel | |||||||||
Other (specify) |
Note 1: Other Combined includes: B/M; B/PWD; B/THI; M/Color Doppler; B/Color Doppler; WD; B/Power Doppler/PWD
Note 2: Tissue Harmonic Imaging.
Note 3: TDI Note 4: 3D
Note 6: Small Organ: breast, thyroid, testes
Note 5: 4D
Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)
Masa S. Patil 3-8
(Division Sign Off)
Division of Office of In and Safety
$$K_{112/1} \leq 1$$
510k
Indications For Use
15
Transducer: C362 Curved Array Diagnostic Ultrasound Transducer
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application | Mode of Operation | Other* | |||||||
---|---|---|---|---|---|---|---|---|---|
General | |||||||||
(TRACK 1 | |||||||||
ONLY) | Specific | ||||||||
(TRACKS 1 & 3) | B | M | PWD | CWD | Color | ||||
Doppler | Power | ||||||||
(Amplitude) | |||||||||
Doppler | Combined | Specify | |||||||
Ophthalmic | Ophthalmic | ||||||||
Fetal | |||||||||
Imaging & | |||||||||
Other | Fetal | P | P | P | P | P | Note 1 | Notes 2,4 | |
Abdominal | P | P | P | P | P | Note1 | Notes 2,4 | ||
Intra-operative Specify | |||||||||
Intra-operative Neuro | |||||||||
Laparoscopic | |||||||||
Pediatric | |||||||||
Small Organ (specify) | |||||||||
Neonatal Cephalic | |||||||||
Adult Cephalic | |||||||||
Trans-rectal | |||||||||
Trans-vaginal | |||||||||
Trans-urethral | |||||||||
Trans-esoph.(non-Card) | |||||||||
Musculo-skeletal | |||||||||
(Conventional) | |||||||||
Musculo-skeletal | |||||||||
(Superficial) | |||||||||
Intravascular | |||||||||
Other (Ob/GYN) | P | P | P | P | P | Note 1 | Notes 2,4 | ||
Cardiac | Cardiac Adult | ||||||||
Cardiac Pediatric | |||||||||
Intravascular(Cardiac) | |||||||||
Trans-esoph.(Cardiac) | |||||||||
Intra-cardiac | |||||||||
Other (specify) | |||||||||
Peripheral | |||||||||
Vessel | Peripheral vessel | ||||||||
Other (specify) | |||||||||
N = new indication: | |||||||||
P = previously cleared by FDA: | |||||||||
E = added under this annendix |
Note 1: Other Combined includes: B/M; B/PWD; B/TH): M/Color M ; B/Color Doppler; B/Color Doppler/PWD; B/Power Doppler/PWD
Note 2: Tissue Harmonic Imaging.
Note 4: 3D Note 3: TDI
Note 6: Small Organ: breast, thyroid, testes
Note 5: 4D
Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)
Mary S. Patel
(Division Sign-Off)
Indications For Use
3-9 Division of Radiological De Office of In Vitro Diagnostic Device Evaluation and Safety
510K K1124S1
16
Transducer: C344 Curved Array Diagnostic Ultrasound Transducer
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application | Mode of Operation | ||||||||
---|---|---|---|---|---|---|---|---|---|
General | |||||||||
(TRACK 1 | |||||||||
ONLY) | Specific | ||||||||
(TRACKS 1 & 3) | B | M | PWD | CWD | Color | ||||
Doppler | Power | ||||||||
(Amplitude) | |||||||||
Doppler | Other* | ||||||||
Combined | Other* | ||||||||
Specify | |||||||||
Ophthalmic | Ophthalmic | ||||||||
Fetal | |||||||||
Imaging& | |||||||||
Other | Fetal | P | P | P | P | P | Note 1 | Notes 2, 4 | |
Abdominal | P | P | P | P | P | Note 1 | Notes 2, 4 | ||
Intra-operative Specify | |||||||||
Intra-operative Neuro | |||||||||
Laparoscopic | |||||||||
Pediatric | |||||||||
Small Organ (specify) | |||||||||
Neonatal Cephalic | |||||||||
Adult Cephalic | |||||||||
Trans-rectal | |||||||||
Trans-vaginal | |||||||||
Trans-urethral | |||||||||
Trans-esoph. (non-Card) | |||||||||
Musculo-skeletal | |||||||||
(Conventional) | |||||||||
Musculo-skeletal | |||||||||
(Superficial) | |||||||||
Intravascular | |||||||||
Other (Ob/GYN) | P | P | P | P | P | Note 1 | Notes 2, 4 | ||
Cardiac | Cardiac Adult | ||||||||
Cardiac Pediatric | |||||||||
Intravascular(Cardiac) | |||||||||
Trans-esoph. (Cardiac) | |||||||||
Intra-cardiac | |||||||||
Other (specify) | |||||||||
Peripheral | |||||||||
Vessel | Peripheral vessel | ||||||||
Other (specify) | |||||||||
N = new indication; | P = previously cleared by FDA; | ||||||||
E = added under this appendix |
Note 1: Other Combined includes: B/M; B/PWD; B/THI; M/Color Doppler; B/Color Doppler/PWD; B/Power Doppler/PWD
Note 2: Tissue Harmonic Imaging.
Note 3: TDI Note 4: 3D
(Part 21 CFR 801 Subpart D)
Note 6: Small Organ: breast, thyroid, testes
X
AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Note 5: 4D
Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)
Indications For Use
Prescription Use
Mury Statt 3-10
(Division Sign-Off)
itro Diagnostic Device valuation and Safety
510F
17
Transducer: VC6-2 Curved Array
Diagnostic Ultrasound Transducer
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application | Mode of Operation | ||||||||
---|---|---|---|---|---|---|---|---|---|
General | |||||||||
(TRACK 1 | |||||||||
ONLY) | Specific | ||||||||
(TRACKS 1 & 3) | B | M | PWD | CWD | Color | ||||
Doppler | Power | ||||||||
(Amplitude) | |||||||||
Doppler | Other* | ||||||||
Combined | Other* | ||||||||
Specify | |||||||||
Ophthalmic | Ophthalmic | P | |||||||
Fetal | |||||||||
Imaging & | |||||||||
Other | Fetal | P | P | P | P | P | Note 1 | Notes 2,4,5 | |
Abdominal | P | P | P | P | P | Note 1 | Notes 2,4,5 | ||
Intra-operative Specify | |||||||||
Intra-operative Neuro | |||||||||
Laparoscopic | |||||||||
Pediatric | |||||||||
Small Organ (specify) | |||||||||
Neonatal Cephalic | |||||||||
Adult Cephalic | |||||||||
Trans-rectal | |||||||||
Trans-vaginal | |||||||||
Trans-urethral | |||||||||
Trans-esoph. (non-Card) | |||||||||
Musculo-skeletal | |||||||||
(Conventional) | |||||||||
Musculo-skeletal | |||||||||
(Superficial) | |||||||||
Intravascular | |||||||||
Other (Ob/GYN) | P | P | P | P | P | Note 1 | Notes 2,4,5 | ||
Cardiac | Cardiac Adult | ||||||||
Cardiac Pediatric | |||||||||
Intravascular(Cardiac) | |||||||||
Trans-esoph.(Cardiac) | |||||||||
Intra-cardiac | |||||||||
Other (specify) | |||||||||
Peripheral | |||||||||
Vessel | Peripheral vessel | ||||||||
Other (specify) |
N = new indication; P = previously cleared by FDA; E = added under this appendix Note 1: Other Combined includes: B/M; B/PWD; B/THI; M/Color M ; B/Color Doppler; B/Color Doppler/PWD; B/Power Doppler/PWD
Note 2: Tissue Harmonic Imaging.
Note 3: TDI Note 4: 3D
(Part 21 CFR 801 Subpart D)
Note 6: Small Organ: breast, thyroid, testes
X
1
AND/OR
Note 5: 4D
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)
Indications For Use
Prescription Use
Marr S. Rotel 3-11
(Division Sign-Off)
and Safety
510k
18
Transducer: L743 Linear Array Diagnostic Ultrasound Transducer
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application | Mode of Operation | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
General | |||||||||||
(TRACK 1 | |||||||||||
ONLY) | Specific | ||||||||||
(TRACKS 1 & 3) | B | M | PWD | CWD | Color | ||||||
Doppler | Power | ||||||||||
(Amplitude) | |||||||||||
Doppler | Other* | ||||||||||
Combined | Other* | ||||||||||
Specify | |||||||||||
Ophthalmic | Ophthalmic | ||||||||||
Fetal | Fetal | ||||||||||
Imaging& | |||||||||||
Other | Abdominal | ||||||||||
Intra-operative Specify | |||||||||||
Intra-operative Neuro | |||||||||||
Laparoscopic | |||||||||||
Pediatric | |||||||||||
Small Organ (specify) | P | P | P | P | P | Note 1 | Notes 2, 4 | ||||
Neonatal Cephalic | |||||||||||
Adult Cephalic | |||||||||||
Trans-rectal | |||||||||||
Trans-vaginal | |||||||||||
Trans-urethral | |||||||||||
Trans-esoph. (non-Card) | |||||||||||
Musculo-skeletal | |||||||||||
(Conventional) | P | P | P | P | P | Note 1 | Notes 2, 4 | ||||
Musculo-skeletal | |||||||||||
(Superficial) | P | P | P | P | P | Note 1 | Notes 2, 4 | ||||
Intravascular | |||||||||||
Other (Ob/GYN) | |||||||||||
Cardiac | Cardiac Adult | ||||||||||
Cardiac Pediatric | |||||||||||
Intravascular(Cardiac) | |||||||||||
Trans-esoph. (Cardiac) | |||||||||||
Intra-cardiac | |||||||||||
Other (specify) | |||||||||||
Peripheral | Peripheral vessel | P | P | P | P | P | Note 1 | Notes 2, 4 | |||
Vessel | Other (specify) | ||||||||||
P = previously cleared by FDA: | |||||||||||
E = added under this appendix | |||||||||||
N = new indication: |
Note 1: Other Combined includes: BM; B/PWD; B/THI; M/Color Doppler; B/Color Doppler; B/Color Doppler/PWD; B/Power Doppler/PWD
Note 2: Tissue Harmonic Imaging.
Note 4: 3D Note 3: TDI
Note 6: Small Organ: breast, thyroid, testes
Note 5: 4D
Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVI)
es (OIVD)
(Division Sign Off)
Division of Badin Office of It
510K K11245-1
Indications For Use
19
Transducer: L741 Linear Array Diagnostic Ultrasound Transducer
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application | Mode of Operation | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
General | ||||||||||
(TRACK 1 | ||||||||||
ONLY) | Specific | |||||||||
(TRACKS 1 & 3) | B | M | PWD | CWD | Color | |||||
Doppler | Power | |||||||||
(Amplitude) | ||||||||||
Doppler | Other* | |||||||||
Combined | Other* | |||||||||
Specify | ||||||||||
Ophthalmic | Ophthalmic | |||||||||
Fetal | ||||||||||
Imaging& | ||||||||||
Other | Fetal | |||||||||
Abdominal | ||||||||||
Intra-operative Specify | ||||||||||
Intra-operative Neuro | ||||||||||
Laparoscopic | ||||||||||
Pediatric | ||||||||||
Small Organ (specify) | P | P | P | P | P | Note 1 | Notes 2, 4 | |||
Neonatal Cephalic | ||||||||||
Adult Cephalic | ||||||||||
Trans-rectal | ||||||||||
Trans-vaginal | ||||||||||
Trans-urethral | ||||||||||
Trans-esoph. (non-Card) | ||||||||||
Musculo-skeletal | ||||||||||
(Conventional) | P | P | P | P | P | Note 1 | Notes 2, 4 | |||
Musculo-skeletal | ||||||||||
(Superficial) | P | P | P | P | P | Note 1 | Notes 2, 4 | |||
Intravascular | ||||||||||
Other (Ob/GYN) | ||||||||||
Cardiac | Cardiac Adult | |||||||||
Cardiac Pediatric | ||||||||||
Intravascular(Cardiac) | ||||||||||
Trans-esoph.(Cardiac) | ||||||||||
Intra-cardiac | ||||||||||
Other (specify) | ||||||||||
Peripheral | ||||||||||
Vessel | Peripheral vessel | P | P | P | P | P | Note 1 | Notes 2, 4 | ||
Other (specify) | ||||||||||
N = new indication; | P = previously cleared by FDA; | E = added under this appendix |
Note 1: Other Combined includes: B/M; B/PWD; B/TH); M/Color Doppler; B/Color Doppler/PWD; B/Power Doppler/PWD
Note 2: Tissue Harmonic Imaging.
Note 3: TDI Note 4: 3D
(Part 21 CFR 801 Subpart D)
Note 6: Small Organ: breast, thyroid, testes
X
AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Note 5: 4D
Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)
Indications For Use
Prescription Use
Macy S. Patel
(Division Sign-Off)
Office of aluation and Safety
510K KiizusT
3-13
20
Transducer: L742 Linear Array Diagnostic Ultrasound Transducer
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical Application | Mode of Operation | ||||||||
---|---|---|---|---|---|---|---|---|---|
General | |||||||||
(TRACK 1 | |||||||||
ONLY) | Specific | ||||||||
(TRACKS 1 & 3) | B | M | PWD | CWD | Color | ||||
Doppler | Power | ||||||||
(Amplitude) | |||||||||
Doppler | Other* | ||||||||
Combined | Other* | ||||||||
Specify | |||||||||
Ophthalmic | Ophthalmic | ||||||||
Fetal | |||||||||
Imaging& | |||||||||
Other | Fetal | ||||||||
Abdominal | |||||||||
Intra-operative Specify | |||||||||
Intra-operative Neuro | |||||||||
Laparoscopic | |||||||||
Pediatric | |||||||||
Small Organ (specify) | P | P | P | P | P | Note 1 | Notes 2, 4 | ||
Neonatal Cephalic | |||||||||
Adult Cephalic | |||||||||
Trans-rectal | |||||||||
Trans-vaginal | |||||||||
Trans-urethral | |||||||||
Trans-esoph. (non-Card) | |||||||||
Musculo-skeletal | |||||||||
(Conventional) | P | P | P | P | P | Note 1 | Notes 2, 4 | ||
Musculo-skeletal | |||||||||
(Superficial) | P | P | P | P | P | Note 1 | Notes 2, 4 | ||
Intravascular | |||||||||
Other (Ob/GYN) | |||||||||
Cardiac | Cardiac Adult | ||||||||
Cardiac Pediatric | |||||||||
Intravascular(Cardiac) | |||||||||
Trans-esoph. (Cardiac) | |||||||||
Intra-cardiac | |||||||||
Other (specify) | |||||||||
Peripheral | |||||||||
Vessel | Peripheral vessel | P | P | P | P | P | Note 1 | Notes 2, 4 | |
Other (specify) |
Note 1: Other Combined includes: BM; B/PW/J; M/Color M ; B/Color Doppler; B/Color Doppler/PWD; B/Power Doppler/PWD
Note 2: Tissue Harmonic Imaging.
Note 3: TDI Note 4: 3D
(Part 21 CFR 801 Subpart D)
Note 6: Small Organ: breast, thyroid, testes
X
AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Note 5: 4D
Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)
Indications For Use
Prescription Use
Mary S. Pfohl
(Division Sign-Off)
Division of Radiological Devices Office of In valuation and Safety
510K KUZUSI
3-14